Clinical trial
Effect and Safety of Adding Metformin to the Standard Treatment of Hepatitis C on Sustained Viral Response
NCT00560690 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect and Safety of Adding Metformin to the Standard Treatment of Hepatitis C on Sustained Viral Response
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- December 31, 2010
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.